Frambinone Production via Genetically Modified Fungal Microorganism
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing frambinone, a valuable natural phenolic compound, are inefficient due to its limited natural availability and high production costs, with existing biotechnological approaches yielding low yields and requiring expensive substrates.
Innovation Solution
A genetically modified fungal microorganism is developed to produce frambinone from tyrosine, incorporating specific enzyme activities such as tyrosine ammonia lyase, 4-coumarate:CoA ligase, benzalacetone synthase, and benzalacetone reductase, with modifications to prevent breakdown of tyrosine into undesirable products, optimizing enzyme expression and activity for enhanced frambinone production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If frambinone is produced by natural extraction from raspberries, then the compound is obtained with high purity, but the production cost is extremely high and yield is very low
Solution Approach 1:
The patent replaces mechanical extraction methods with biological synthesis using genetically modified microorganisms. The microorganisms express plant-derived enzymes (CHS, 4CL, BAR) to biosynthesize frambinone from simple precursors, substituting physical extraction with biochemical production pathways.
Solution Approach 2:
The patent uses microorganisms as living factories that act as intermediaries between simple chemical precursors (coumaric acid, malonyl-CoA) and the target compound frambinone. These microorganisms provide the enzymatic machinery to convert inexpensive substrates into high-value frambinone through controlled metabolic pathways.
2Productivity
If chemical synthesis methods are used to produce frambinone, then production volume can be increased, but production cost remains high and environmental impact increases
Solution Approach 1:
The patent replaces complex multi-step chemical synthesis with a biological production system using genetically modified microorganisms. The biological pathway uses enzymatic reactions that occur under mild conditions, eliminating the need for harsh chemicals, high temperatures, and complex purification steps required in traditional chemical synthesis.
Solution Approach 2:
The patent changes the production parameters from extreme chemical conditions (high temperature, pressure, toxic solvents) to mild biological conditions (physiological temperature, aqueous environment, pH neutral). This enables scalable production while reducing environmental impact and simplifying manufacturing.
3Ease of manufacture
If existing biotechnological approaches are used to produce frambinone, then production cost is reduced, but yield remains low and substrate cost is high
Solution Approach 1:
The patent changes the substrate from expensive natural extracts or complex precursors to inexpensive, readily available compounds like coumaric acid and malonyl-CoA. The genetic modifications in the microorganisms optimize the metabolic pathway to efficiently convert these cheap substrates into frambinone, achieving both low cost and high yield.
Solution Approach 2:
The patent divides the frambinone production pathway into discrete enzymatic steps, each catalyzed by a specific introduced enzyme (CHS for chalcone formation, 4CL for coumaroyl-CoA synthesis, BAR for frambinone production). This modular approach allows optimization of each step and efficient use of inexpensive substrates.
4Ease of manufacture
If tyrosine is used as substrate for frambinone production, then substrate cost is reduced and availability is improved, but tyrosine breakdown into by-products competes with frambinone synthesis
Solution Approach 1:
The patent converts the harmful competitive breakdown pathway into a beneficial route by introducing enzymes that channel tyrosine metabolism toward frambinone production. The introduced enzymes (TAL, 4CL, BAS, BAR) capture tyrosine and redirect it through the desired pathway, turning the competing degradation route into productive frambinone synthesis.
Solution Approach 2:
The patent introduces specific enzymes as intermediaries to mediate the conversion of tyrosine to frambinone. These enzymes act as selective catalysts that preferentially channel tyrosine through the frambinone pathway, preventing spontaneous breakdown into by-products and ensuring high selectivity and reliability of the production process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach achieves significantly higher frambinone production levels, up to 30 mg/L, with improved efficiency and reduced by-product formation, making the process more economically viable by utilizing tyrosine as a substrate.
Implementation Method 1
Tyrosine is deaminated by a tyrosine ammonia-lyase TAL, EC 4.3.1.23) to form coumaric acid
Implementation Method 2
Catalyzed by a 4-coumerate:CoA ligase (4CL, EC 6.2.1.12), a Coenzyme A (CoA) molecule is grafted onto coumaric acid
Implementation Method 3
The coumaroyl-CoA is then converted by a benzalacetone synthase (BAS, EC 2.3.1.212) into 4-hydroxybenzalacetone. This reaction is a decarboxylating condensation and uses a malonyl-CoA unit as co-substrate
Implementation Method 4
The final step is reduction of the 4-hydroxybenzalacetone to frambinone by a benzalacetone reductase (BAR EC 1.3.1.x)
Data Source
AI summary
The invention relates to a genetically modified fungal microorganism for the production of frambinone, the microorganism having the following characteristics: —the capacity to produce frambinone from tyrosine; and —a limited capacity or no capacity to break tyrosine down into tyrosol, p-hydroxyphenylacetaldehyde and/or p-hydroxyphenylacetate; and to the use of same for producing frambinone.